Wednesday 26 April 2017

Pharmaceutical Robots Market worth 119.5 Million USD by 2021

The report "Pharmaceutical Robots Market by Type (Traditional Robots (Articulated Robots, SCARA Robots, Delta Robots, Cartesian Robots), Collaborative Robots), Application (Picking and Packaging, Laboratory Applications) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges.

Browse 98 market data tables and 40 figures spread through 141 pages and in-depth TOC on "Pharmaceutical Robots Market by Type (Traditional Robots (Articulated Robots, SCARA Robots, Delta Robots, Cartesian Robots), Collaborative Robots), Application (Picking and Packaging, Laboratory Applications) - Global Forecast to 2021"


This report studies the global pharmaceutical robots market for the forecast period of 2016 to 2021. This market is expected to reach USD 119.5 Million by 2021 from USD 64.4 Million in 2016, at a CAGR of 13.2% during the forecast period. The key factor driving the growth of the market is the benefits offered by robotic systems in pharmaceutical manufacturing.

The global pharmaceutical robots market is segmented on the basis of type, application, and region.
Based on type, the market is segmented into traditional robots and collaborative robots. The traditional robots segment is expected to command the largest share of the global market. The traditional robots segment is further categorized into articulated, SCARA (selective compliance articulated robot arm), delta/parallel, Cartesian, and other robots (which include spherical and dual-arm robots). The articulated robots segment accounted for the largest share of the global pharmaceutical traditional robots market in 2016.

On the basis of application, the global pharmaceutical robots market is segmented into picking and packaging, inspection of pharmaceutical drugs, and laboratory applications. In 2016, the picking and packaging segment accounted for the largest share of the global pharmaceutical robots market. Factors such as demand for personalized packaging configurations and advantages of robots in pharmaceutical manufacturing such as high speed, accuracy, ability to track and trace, error-free operation, fewer accidents, and better utilization of the floor space are contributing to the large share of the picking and packaging segment.

Based on region, the pharmaceutical robots market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, Asia-Pacific accounted for the largest share of the global market. This segment is also projected to register the highest CAGR of 14.1% during the forecast period. Factors such as the increase in domestic industrial robot companies, flourishing pharmaceutical industry, increasing number of conferences and exhibitions, investment and funding in the robots industry, and Japan’s Robot Strategy are driving the growth of the APAC pharmaceutical robots market.

Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd. (Switzerland), Denso Corporation (Japan), Seiko Epson Corporation (Japan), Marchesini Group S.p.A (Italy), Universal Robots A/S (Denmark), Yaskawa Electric Corporation (Japan), and Shibuya Corporation (Japan) are the prominent players in the global pharmaceutical robots market.


Wednesday 19 April 2017

Varicose Vein Treatment Market in North America and Europe worth 289.7 Million USD by 2021

The report "Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021", The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021.


The report provides a detailed overview of the major drivers, restraints, opportunities, and challenges impacting the varicose vein treatment market in North America and Europe along with the estimates and forecasts of the revenue and market share analysis.
The varicose vein treatment market is poised to witness a steady growth between 2016 and 2021. Shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, huge burden of varicose vein cases in North America and Europe, improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population will majorly drive the varicose vein treatment market.


This report broadly segments the varicose vein treatment market into mode of treatment and products. The varicose vein treatment market, by products is segmented into ablation devices, venous closure products, and surgical products. The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices. On the basis of mode of treatment, the varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping.

This report covers the varicose vein treatment market across two major geographies, namely, North America and Europe. In this report, the North American varicose vein treatment market is further segmented into the U.S. and Canada, while the European varicose vein treatment market is categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe. In 2016, North America is expected to command the largest share of the varicose vein treatment market in North America and Europe. However, Europe is expected to register the highest growth rate during the forecast period from 2016 to 2021, due to increasing adoption of advanced treatment procedures and favorable government initiatives in this region.

Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.) are the key players in the varicose vein treatment market.

About MarketsandMarkets

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. 

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441

Tuesday 18 April 2017

Pharmaceutical Robots Market worth 119.5 Million USD by 2021

The report "Pharmaceutical Robots Market by Type (Traditional Robots (Articulated Robots, SCARA Robots, Delta Robots, Cartesian Robots), Collaborative Robots), Application (Picking and Packaging, Laboratory Applications) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges.


Browse 98 market data tables and 40 figures spread through 141 pages and in-depth TOC on "Pharmaceutical Robots Market by Type (Traditional Robots (Articulated Robots, SCARA Robots, Delta Robots, Cartesian Robots), Collaborative Robots), Application (Picking and Packaging, Laboratory Applications) - Global Forecast to 2021"


Full Report @ http://www.marketsandmarkets.com/Market-Reports/pharmaceutical-robot-market-210985096.html

Early buyers will receive 10% customization on reports.

This report studies the global pharmaceutical robots market for the forecast period of 2016 to 2021. This market is expected to reach USD 119.5 Million by 2021 from USD 64.4 Million in 2016, at a CAGR of 13.2% during the forecast period. The key factor driving the growth of the market is the benefits offered by robotic systems in pharmaceutical manufacturing.


Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=210985096

Based on type, the market is segmented into traditional robots and collaborative robots. The traditional robots segment is expected to command the largest share of the global market. The traditional robots segment is further categorized into articulated, SCARA (selective compliance articulated robot arm), delta/parallel, Cartesian, and other robots (which include spherical and dual-arm robots). The articulated robots segment accounted for the largest share of the global pharmaceutical traditional robots market in 2016.

On the basis of application, the global pharmaceutical robots market is segmented into picking and packaging, inspection of pharmaceutical drugs, and laboratory applications. In 2016, the picking and packaging segment accounted for the largest share of the global pharmaceutical robots market. Factors such as demand for personalized packaging configurations and advantages of robots in pharmaceutical manufacturing such as high speed, accuracy, ability to track and trace, error-free operation, fewer accidents, and better utilization of the floor space are contributing to the large share of the picking and packaging segment.

Based on region, the pharmaceutical robots market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, Asia-Pacific accounted for the largest share of the global market. This segment is also projected to register the highest CAGR of 14.1% during the forecast period. Factors such as the increase in domestic industrial robot companies, flourishing pharmaceutical industry, increasing number of conferences and exhibitions, investment and funding in the robots industry, and Japan’s Robot Strategy are driving the growth of the APAC pharmaceutical robots market.

Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd. (Switzerland), Denso Corporation (Japan), Seiko Epson Corporation (Japan), Marchesini Group S.p.A (Italy), Universal Robots A/S (Denmark), Yaskawa Electric Corporation (Japan), and Shibuya Corporation (Japan) are the prominent players in the global pharmaceutical robots market.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com